首页 产品目录 分子砌块 按反应类型 胺化 (R)-(5-methyl-3-(morpholinomethyl)-2,3-dihydro-[1,4]oxazino[2,3,4-hi]indol-6-yl)(naphthalen-1-yl)methanone methanesulfonate

(R)-(5-methyl-3-(morpholinomethyl)-2,3-dihydro-[1,4]oxazino[2,3,4-hi]indol-6-yl)(naphthalen-1-yl)methanone methanesulfonate

(R)-(5-methyl-3-(morpholinomethyl)-2,3-dihydro-[1,4]oxazino[2,3,4-hi]indol-6-yl)(naphthalen-1-yl)methanone methanesulfonate

产品编号 :
Cas No. :
包装规格 纯度 目录价 会员专享价 库存 数量
5mg 95% 询价
- +
25mg 95% 询价
- +
晶智化学产品均仅供科研使用。在任何情况下,我们均不提供用于动物或人体用途的产品或服务。

基础信息

CAS No.

131543-23-2

英文名称

(R)-(5-methyl-3-(morpholinomethyl)-2,3-dihydro-[1,4]oxazino[2,3,4-hi]indol-6-yl)(naphthalen-1-yl)methanone methanesulfonate

别名

(+)-WIN 55,212-2 mesylate - CAS 131543-23-2 - Calbiochem;CS-754;WIN552122;WIN-552122;R(+)-WIN 55,212-2 ,MESYLATE HIGH AFFINIT Y CANNABI;(R)-(+)-(2,3-Dihydro-5-methyl-3-(4-morpholinylmethyl)pyrrolo[1.2.3-de]-1,4-benzoxazin-6-yl)-1-naphthalenylmethanonemesy;212-2Mesylate;WIN55;(R)-(+)-[2,3-Dihydro-5-methyl-3[(4-morpholinyl)methyl]pyrrolo[1,2,3-de]-1,4-benzoxazinyl]-(1-naphthalenyl)methanone mesylate salt

标准英文名

(R)-(5-methyl-3-(morpholinomethyl)-2,3-dihydro-[1,4]oxazino[2,3,4-hi]indol-6-yl)(naphthalen-1-yl)methanone methanesulfonate

分子式

C28H30N2O6S

分子量

522.62

精确分子量

522.18

SMILES

CC1=C(C(=O)C2=CC=CC3=CC=CC=C32)C2=C3C(=CC=C2)OC[C@@H](CN2CCOCC2)N13.CS(=O)(=O)O

标准SMILES

CC1=C(C(=O)C2=CC=CC3=CC=CC=C32)C2C=CC=C3OC[C@@H](CN4CCOCC4)N1C=23.CS(O)(=O)=O

用途

(R)-(+)-WIN 55,212-2 mesylate is a potent cannabinoid (CB) receptor agonist with high affinity for human recombinant CB2 (Ki = 3.3 nM) and CB1 (Ki = 62.3 nM) receptors; it modulates glutamatergic transmission; it increases extracellular glutamate levels in primary cultures of rat cerebral cortex neurons and enhances dialysate glutamate levels in the prefrontal cortex of awake rats; it evokes CGRP release from trigeminal ganglion (TG) neurons in a concentration- and calcium-dependent manner; it significantly inhibits 50 mM K⁺-evoked CGRP release; it exhibits anticonvulsant effects in a dose-dependent manner, which can be potentiated by pioglitazone pre-treatment.

InChIKey

FSGCSTPOPBJYSX-VEIFNGETSA-N

安全信息

SureRoute逆合成路线

1.  131543-23-2 逆合成路线 1

ACJBHK280
282089-49-0
—
—
ACUCGM554
131543-23-2
来源: SureRoute

2.  131543-23-2 逆合成路线 2

—
—
ACUCGM554
131543-23-2
来源: SureRoute

3.  131543-23-2 逆合成路线 3

—
—
—
—
ACUCGM554
131543-23-2
来源: SureRoute
评论 0
我是晶智Agent,
您的化学小助手